Page last updated: 2024-09-05
sb 216763 and fh535
sb 216763 has been researched along with fh535 in 1 studies
Compound Research Comparison
Studies (sb 216763) | Trials (sb 216763) | Recent Studies (post-2010) (sb 216763) | Studies (fh535) | Trials (fh535) | Recent Studies (post-2010) (fh535) |
---|---|---|---|---|---|
342 | 0 | 225 | 42 | 0 | 40 |
Research
Studies (1)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors
Authors | Studies |
---|---|
Chen, HM; Kao, SH; Kuo, CY; Tzang, BS; Wang, WC | 1 |
Other Studies
1 other study(ies) available for sb 216763 and fh535
Article | Year |
---|---|
IL-6 augmented motility of airway epithelial cell BEAS-2B via Akt/GSK-3β signaling pathway.
Topics: Androstadienes; beta Catenin; Biological Assay; Carrier Proteins; Cell Line, Transformed; Cell Movement; Diffusion Chambers, Culture; Dose-Response Relationship, Drug; Epithelial Cells; Gene Expression Regulation; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Humans; Indoles; Interleukin-6; Lithium Chloride; Maleimides; Microfilament Proteins; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Proto-Oncogene Proteins c-akt; Respiratory System; RNA, Messenger; Signal Transduction; Sulfonamides; Wortmannin; Wound Healing | 2012 |